Small-Cap
Janux Therapeutics Unveils Promising Updates on Cancer Treatments
Janux Therapeutics Inc (JANX) disclosed updated findings on its experimental drugs, JANX007 and JANX008, showcasing significant progress in treating metastatic...
Archer Aviation Misses Q4 Estimates that Results in Declining Share Price
Archer Aviation Inc (ACHR) disclosed its fourth-quarter financial results on Monday, disappointing analysts' expectations. The Breakdown: Archer Aviation posted losses...
Weathering the Storm: Mativ Holdings’ Strategic Voyage
In the wake of challenging market conditions, Mativ Holdings, Inc. (MATV) finds itself on a tumultuous yet hopeful journey. Despite...
Ocular Therapeutix Announces Private Placement to Bolster Clinical Development Initiatives
Ocular Therapeutix, Inc. (OCUL), a pioneering biopharmaceutical company dedicated to advancing vision-related therapies, has disclosed its strategic move to enhance...
Regenxbio’s RGX-121 Trial Achieves Major Milestone in Hunter Syndrome Treatment
Regenxbio Inc. (Nasdaq: RGNX) has announced significant progress in its Phase I/II/III CAMPSIITE® trial of RGX-121 for the treatment of...
